It is not easy to be the CEO of a company that falls deeper and deeper the way Advanced Life Sciences Holdings Inc.(OTC:ADLS) does. Two years ago, Michael Flavin enjoyed a daily session of 18 million shares traded at the price of $1.4. This March, he did not enjoy the new all-time high in the volumes. This time, more than 20 million shares were traded, the session closing at $0.01. 
In fact, the only things that came out of this company this week were its financial statements. Indeed, the statements included could have served for the free fall on the stock market yesterday. Here are a few extracts from the 10-k report with an end date Dec. 31, 2010:
Apart from the above numbers, there is other data, also not very appealing. For example, none of the company’s product candidates have been approved by the FDA or any comparable foreign agency. What is more, due to a default on the company line of credit arrangement, there is a possibility that Advanced Life would have to file for bankruptcy. The whole document can be reviewed here. [BANNER]
One fact that should also be taken into consideration is that the company is currently seeking alternative means to sustain its business and eventually come out of the bad situation it fell into. A possible way, according to Advanced Life Science, is also to be acquired by another company. This means two things – announcements related to such actions might be able to push the stock price up again, even for a short while. On the long run, ADLS could recover some of its lost positions, meaning a lucrative investment return for the ones who bought shares this year. 
